Financial Network Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.3K Buy
334
+74
+28% +$11.1K 0.05% 273
2026
Q1
$39.7K Buy
260
+121
+87% +$18.5K 0.04% 301
2025
Q4
$19.2K Buy
139
+52
+60% +$6.81K 0.02% 392
2025
Q3
$11.2K Buy
87
+30
+53% +$3.66K 0.01% 440
2025
Q2
$6.9K Buy
57
+11
+24% +$1.24K 0.01% 483
2025
Q1
$5.13K Buy
46
+7
+18% +$745 0.01% 496
2024
Q4
$3.79K Sell
39
-18
-32% -$1.92K 0.01% 372
2024
Q3
$6.56K Buy
57
+11
+24% +$1.25K 0.01% 499
2024
Q2
$4.9K Buy
+46
New +$4.62K ﹤0.01% 584

Other funds holding NVS

Financial Network Wealth Advisors's NVS Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Novartis (NVS) stake by 28% in Q2 2026, buying an estimated $11.1K and bringing the position to 334 shares worth $52.3K. The position accounts for 0.05% of the portfolio, ranked #273.

Financial Network Wealth Advisors first reported a position in NVS in Q2 2024 and has held it in 9 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Financial Network Wealth Advisors held 334 shares of Novartis worth $52.3K as of Q2 2026.
  • Financial Network Wealth Advisors bought 74 Novartis shares in Q2 2026, an estimated $11.1K.
  • Novartis made up 0.05% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #273 holding.
  • Financial Network Wealth Advisors first reported a position in Novartis in Q2 2024 and has held it in 9 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.